Clinical Trial Update: Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated the safety and preliminary efficacy of combining amifostine with topotecan in patients with leukemia and myelodysplastic syndromes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Amifostine (amifostine)
• Topotecan (topotecan)

Snippet

Sponsor: University of Arizona | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED